Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
21
Number of overlapping holdings
10.7%
% of IBBQ's 197 holdings also in HRTS
53.8%
% of HRTS's 39 holdings also in IBBQ
Overlap by Weight
Sector Drift (IBBQ minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 8.4% | 5.7% | 5.7% |
|
AMGEN INC | 7.6% | 5.1% | 5.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.3% | 4.7% | 3.3% |
|
REGENERON PHARMACEUTICALS | 5.7% | 2.4% | 2.4% |
|
ASCENDIS PHARMA A/S | 0.8% | 3.1% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
IBBQ Overweight Relative to HRTS
|
GILEAD SCIENCES INC | 10.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.0% |
|
REGENERON PHARMACEUTICALS | 3.3% |
|
VERTEX PHARMACEUTICALS INC | 2.7% |
|
BIOGEN IDEC INC | 2.5% |
|
AMGEN INC | 2.4% |
|
ILLUMINA INC | 2.3% |
 |
ARGENX SE ADR | 2.0% |
|
UNITED THERAPEUTICS CORP | 1.8% |
|
VIATRIS, INC. | 1.6% |
IBBQ Underweight Relative to HRTS
|
ELI LILLY & CO | -6.4% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
 |
NOVO NORDISK A/S-B | -3.6% |
|
CRINETICS PHARMACEUTICALS INC | -3.4% |
|
BRIDGEBIO PHARMA, INC. | -3.3% |
|
ASTRAZENECA PLC | -3.1% |
|
BOSTON SCIENTIFIC CORP | -3.1% |
 |
MEDTRONIC PLC | -3.0% |
|
DEXCOM INC | -2.7% |
|
CYTOKINETICS INC | -2.7% |